[Strategy of immunosuppressants usage for subjects with loss of renal function and infection control on RPGN].
Yoshida
Masaharu
M
D001323:Autoantibodies; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects; D015267:Churg-Strauss Syndrome; D000075202:Contraindications; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects; D018450:Disease Progression; D004347:Drug Interactions; D050533:Glomerular Basement Membrane / Q000276:immunology; D005921:Glomerulonephritis / Q000188:drug therapy*; D014890:Granulomatosis with Polyangiitis; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D009894:Opportunistic Infections / Q000209:etiology* / Q000517:prevention & control*; D020551:Pulse Therapy, Drug; D012720:Severity of Illness Index
D001323:Autoantibodies; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003520:Cyclophosphamide; D001379:Azathioprine